Literature DB >> 14734614

Analysis of autoreactive T cells associated with murine collagen-induced arthritis using peptide-MHC multimers.

Jason C Huang1, Mikael Vestberg, Alfredo Minguela, Rikard Holmdahl, E Sally Ward.   

Abstract

CD4(+) T cells that recognize residues 256-270 of type II collagen (CII) associated with the I-A(q) (A(q)) molecule play a central role in disease pathogenesis in murine collagen-induced arthritis (CIA). Disease is most efficiently induced by immunization with heterologous CII, which elicits heterologous, e.g. bovine, CII256-270:I-A(q)-specific T cells that only poorly cross-react with mouse CII. The self-epitope differs from heterologous CII256-270 by a conservative change of glutamic acid (heterologous) to aspartic acid (mouse) at position 266 which confers a lower affinity for binding to the I-A(q) molecule. To date, characterization of the nature of T cell recognition in this model has been hindered by the lack of suitable, labeled multimeric peptide-MHC class II complexes. Here, we describe the biochemical properties of both recombinant bovine CII256-270:I-A(q) (bCII256-270:I-A(q)) and mouse CII256-270:I-A(q) (mCII256-270:I-A(q)) complexes, and use these as fluorescently labeled multimers (tetramers) to characterize the specificity of CII-reactive T cells. Our analyses show that an unexpectedly high percentage of bCII256-270:I-A(q)-specific T cells are cross-reactive with mCII256-270:I-A(q). Interestingly, one T cell clone which has a relatively high avidity for binding to self-CII256-270:I-A(q) shows a marked increase in binding avidity at physiological temperature, indicating that this TCR has unusual thermodynamic properties. Taken together, our analyses suggest that the low affinity of mCII256-270 for I-A(q) may lead to a state of ignorance which can be overcome by priming CII-specific T cells with heterologous CII. This has relevance to understanding the mechanism by which CIA is induced and provides an explanation for the low arthritogenicity of mouse CII.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734614     DOI: 10.1093/intimm/dxh039

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  7 in total

1.  CXC chemokine receptor 4 expressed in T cells plays an important role in the development of collagen-induced arthritis.

Authors:  Soo-Hyun Chung; Keisuke Seki; Byung-Il Choi; Keiko B Kimura; Akihiko Ito; Noriyuki Fujikado; Shinobu Saijo; Yoichiro Iwakura
Journal:  Arthritis Res Ther       Date:  2010-10-12       Impact factor: 5.156

2.  Visualization and phenotyping of proinflammatory antigen-specific T cells during collagen-induced arthritis in a mouse with a fixed collagen type II-specific transgenic T-cell receptor β-chain.

Authors:  Patrick Merky; Tsvetelina Batsalova; Robert Bockermann; Balik Dzhambazov; Bettina Sehnert; Harald Burkhardt; Johan Bäcklund
Journal:  Arthritis Res Ther       Date:  2010-08-03       Impact factor: 5.156

3.  Bifunctional Peptide Inhibitors Suppress Interleukin-6 Proliferation and Ameliorates Murine Collagen-Induced Arthritis.

Authors:  Barlas Büyüktimkin; Paul Kiptoo; Teruna J Siahaan
Journal:  J Clin Cell Immunol       Date:  2014-12

4.  Availability of autoantigenic epitopes controls phenotype, severity, and penetrance in TCR Tg autoimmune gastritis.

Authors:  Ditza Levin; Richard J DiPaolo; Carine Brinster; Maria Jamela R Revilleza; Lisa F Boyd; Luc Teyton; Kannan Natarajan; Michael G Mage; Ethan M Shevach; David H Margulies
Journal:  Eur J Immunol       Date:  2008-12       Impact factor: 5.532

5.  Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.

Authors:  Kutty Selva Nandakumar; Johan Bäcklund; Mikael Vestberg; Rikard Holmdahl
Journal:  Arthritis Res Ther       Date:  2004-09-23       Impact factor: 5.156

Review 6.  Applicability and implementation of the collagen-induced arthritis mouse model, including protocols (Review).

Authors:  Jing Luan; Zhifang Hu; Jianghong Cheng; Ruisan Zhang; Peng Yang; Huifang Guo; Gang Nan; Na Guo; Xingchun Gou
Journal:  Exp Ther Med       Date:  2021-07-01       Impact factor: 2.447

7.  Functional recombinant MHC class II molecules and high-throughput peptide-binding assays.

Authors:  Sune Justesen; Mikkel Harndahl; Kasper Lamberth; Lise-Lotte B Nielsen; Søren Buus
Journal:  Immunome Res       Date:  2009-05-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.